University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders

dc.contributor.authorKopp, Katherine O.
dc.contributor.authorGreer, Margaret E.
dc.contributor.authorGlotfelty, Elliot J.
dc.contributor.authorHsueh, Shih-Chang
dc.contributor.authorTweedie, David
dc.contributor.authorKim, Dong Seok
dc.contributor.authorReale, Marcella
dc.contributor.authorVargesson, Neil
dc.contributor.authorGreig, Nigel H
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Research Excellence in Musculoskeletal Health: Collaborate. Innovate. Translate.en
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cell, Developmental and Cancer Biologyen
dc.date.accessioned2023-04-27T08:45:01Z
dc.date.available2023-04-27T08:45:01Z
dc.date.issued2023-04-26
dc.descriptionAcknowledgements The authors acknowledge support from their associated institutions which included: (i) the Intramural Research Program, National Institute on Aging, NIH, USA, (ii) the Karolinska Institutet, Sweden, (iii) Aevisbio Inc., USA, (iv) Aevis Bio Inc., Republic of Korea, (v) G. d’Annunzio University of Chieti and Pescara, Italy, and (vi) University of Aberdeen, Scotland, UK. Funding The generation of this article was supported by: (i) the Intramural Research Program, National Institute on Aging, NIH: AG000994. (ii) The Technology Development Program of MSS, Republic of Korea (S2782046). (iii) The National Research Foundation (NRF) grant funded by the Republic of Korea Government (2021M3A9G2015889).en
dc.description.statusPeer revieweden
dc.format.extent34
dc.format.extent6954606
dc.identifier239256531
dc.identifier9da4efaa-0bd5-4af3-944b-d5bc1270d8bb
dc.identifier37238617
dc.identifier85160373160
dc.identifier.citationKopp, K O, Greer, M E, Glotfelty, E J, Hsueh, S-C, Tweedie, D, Kim, D S, Reale, M, Vargesson, N & Greig, N H 2023, 'A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders', Biomolecules, vol. 13, no. 5, 747. https://doi.org/10.3390/biom13050747en
dc.identifier.doi10.3390/biom13050747
dc.identifier.issn2218-273X
dc.identifier.otherORCID: /0000-0001-8027-114X/work/145270776
dc.identifier.urihttps://hdl.handle.net/2164/20579
dc.language.isoeng
dc.relation.ispartofBiomoleculesen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectImmunomodulatory imide drugs (IMiDs)en
dc.subjectthalidomideen
dc.subjectpomalidomideen
dc.subjectneuroinflammationen
dc.subjectcereblonen
dc.subjecttraumatic brain injury;en
dc.subjectAlzheimer’s diseaseen
dc.subjectParkinson’s diseaseen
dc.subjectneurodegenerationen
dc.subjecterythema nodosum leprosumen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleA New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disordersen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Kopp_etal_B_A_New_Generation_VoR.pdf
Size:
6.63 MB
Format:
Adobe Portable Document Format

Collections